Author: Ankit dhimmar

Most healthtech startups do not die from a bad idea. They die from a good idea built too big. The founder raises a seed round, spends nine months and most of the money building a full platform, and runs out of runway before a single clinician or patient has used the thing for real. Healthtech startup MVP development is the fix for that pattern. It is the discipline of building the smallest honest version that proves your idea works and keeps patient data safe, and nothing more, until the market tells you what to build next. Done well, healthtech MVP development is less about writing code and more about restraint.

The safe part is what makes healthcare different. In most industries you can ship fast, cut a few corners on security, and tidy up later. In healthcare the corner you cut is someone’s medical record, and the rules do not care that you are small. A data breach during your MVP carries the same legal weight as one at a company with millions of users. So the goal is not only to build less. It is to build less while getting the few things that matter exactly right.

We have built medical software since 2016, including JoinBeet, a nutrition platform that syncs with wearables, and Careslate, a translation tool used in clinical settings. This guide is the long version of the advice we give founders on the first call: what an MVP really is, what compliance actually costs you, how to decide what to cut, and the specific mistakes that quietly drain a seed round.

Key takeaways

• An MVP is the smallest compliant version that proves one core loop. If your description has several “ands,” you are describing a full product, not an MVP.
• In the US, a healthcare MVP from an experienced team usually runs $100,000 to $400,000, and HIPAA work adds roughly 40 to 80 percent over a comparable consumer app.
• Most properly scoped healthcare MVPs take three to six months. A quote of a few weeks almost always means compliance was left out of the plan.
• Build compliance in from sprint one: encryption, role-based access, multi-factor login, audit logs, and a signed BAA with every vendor that touches patient data. Retrofitting later costs three to five times more.
• Cut everything that is not the core loop, validate with real clinicians before building, and keep full ownership of your code and IP.

MVP, prototype, or full product? Know what you are building

These three words get used as if they mean the same thing, and the confusion is expensive. A prototype is a clickable mockup. It shows how the app looks and moves, has no real backend, and stores no real data. You build it in days to test an idea with users, not to launch. An MVP is a working product with the single core feature that delivers value, built properly enough to put in front of real patients or providers, with real compliance behind it. A full product is the whole vision: the roadmap, the integrations, the polish, the second and third user types.

Founders who ask for an MVP but describe a full product are the ones who blow the budget, and it happens on almost every first call. Here is the quick test we use out loud: read your feature list back. If it has more than one “and” in it, you are probably describing a full product. “Patients log symptoms and providers review them” is an MVP. “Patients log symptoms and providers review them and there is a billing module and a pharmacy integration and a family portal” is a two-year platform wearing an MVP costume.

The reason this matters so much in healthcare is that every extra feature is not just extra build time. It is extra data, extra access paths, extra compliance surface, and extra ways to leak something you should not. In consumer software, scope creep costs money. In healthtech, it costs money and risk.

Why healthcare MVPs cost more than regular apps

Take any app idea, add the words “for patients,” and the price roughly doubles. The real cost of healthtech MVP development is not agencies padding the invoice. It is where the work actually goes.

• Compliance is architecture, not a feature. HIPAA shapes how you store data, who can see it, how it moves, and how long you keep the logs. These are foundational decisions. Change them after launch and you are rebuilding the plumbing with the water still running.
• Security has to be real, not theater. Encryption at rest and in transit, multi-factor login, role-based access, tamper-proof audit trails. On a to-do app these are nice to have. On a health app they are the product, and reviewers will check.
• You need clinical input. A clinician has to tell you what is safe, what is a liability, and what workflow a nurse will actually tolerate on a night shift. That review time is real, skilled work, and it is not optional.
• Formal QA and documentation. Healthcare software carries a paper trail: what you tested, what you decided, why. That rigor protects you, and it takes time.

Industry guides put a US healthcare MVP from an experienced agency somewhere between $100,000 and $400,000, with the HIPAA work adding roughly 40 to 80 percent over the same app without it. Treat those as ranges, not a quote. The honest number for your product comes after someone scopes it, because a symptom tracker and a remote patient monitoring platform are not the same job. The one figure to burn into memory: retrofitting compliance after launch runs three to five times more than building it in from the start. Anyone quoting you six weeks and a bargain price has either not understood the compliance load or is planning to hand you the bill for it later.

How much does a healthcare MVP actually cost?

Cost is the first question almost every founder asks, so let us break the range down instead of hiding behind “it depends.” The cost of healthtech MVP development is driven by four things: how much protected health information you touch, how many integrations you need, how many user types you support at launch, and how senior the team is.

At the lower end, near $100,000, you have a single user type, one core loop, minimal integrations, and a team that has done this before so they are not learning HIPAA on your dime. In the middle you add real integrations, a second workflow, and more clinical validation. At the top, past $300,000, you are usually looking at device data, third-party medical systems, or a product that edges toward being regulated as a medical device, which changes everything.

Watch the costs nobody warns you about. Compliance counsel to confirm what rules apply. Security review or a light penetration test before launch. BAA-eligible hosting, which costs more than a standard cloud plan. Ongoing maintenance, which for any live health product runs meaningfully higher than a consumer app because you cannot let dependencies or security patches drift. Budget for the year, not just the build, or you will ship the MVP and then discover you cannot afford to keep it alive.

How long does it take to build a healthcare MVP?

Three to six months is the honest range for healthtech MVP development that is properly scoped. The spread depends on the same things that drive cost: compliance depth, integrations, and how disciplined you are about scope.

A rough shape of those months: a couple of weeks on scoping, architecture, and confirming which rules apply, so you are not designing blind. Then the build in short cycles, with the compliance foundations going in first, not last. Then testing, including on real devices and against the security requirements, not just a simulator. Then a careful launch. The teams that hit the short end of that range are the ones that cut scope hard and had a clinician in the room early. The teams that blow past six months are almost always the ones who kept saying “while we are at it, let us also add.”

HIPAA and FDA: what compliance really means for your MVP

This is the section founders skim and then regret skimming. Two different rulebooks can apply to a health app, and they answer different questions.

HIPAA is about protecting health data. It kicks in the moment your app stores, processes, or transmits protected health information, which is basically identifiable health data. Telemedicine apps, patient monitoring, anything tied to a clinic or a diagnosis: HIPAA applies. If your app genuinely never touches protected health information, a pure wellness tracker with no identifiable medical data, your obligations are much lighter. The trap is assuming you are in the light category when you are not, so get a straight answer early, ideally from someone who has shipped in healthcare before. The US Department of Health and Human Services publishes the actual rules at hhs.gov/hipaa.

For an MVP, being HIPAA compliant does not mean a full enterprise security program. It means the foundations are right from sprint one: data encrypted at rest and in transit, role-based access so people see only what they should, multi-factor login, a tamper-proof audit log of who touched what, and a signed Business Associate Agreement with every vendor that handles patient data on your behalf.

That last one matters more than founders expect. Missing BAAs are the single most common compliance failure in audited cases, and they are the easiest thing to forget when you are wiring up a third-party service at 11pm.

FDA is a separate question, and it is about risk, not data. Your app may be regulated as a medical device if it is meant to diagnose, treat, cure, or prevent disease, or to affect the structure or function of the body. A symptom logger that helps a patient track how they feel is usually fine. An app that reads sensor data and tells someone they are having a cardiac event is a different animal.

The FDA classifies devices into three risk classes and, for many low-risk apps, intends to exercise enforcement discretion, meaning it will not enforce the full requirements. Higher-risk functions can need a 510(k) clearance or, at the top, premarket approval. The FDA lays out which software functions it regulates at fda.gov.

None of this is legal advice, and that is the point: before you build, get a short read from someone who knows this area, because the answer changes your architecture, your timeline, and your budget.

The data security your MVP needs on day one

Strip the jargon and this is a short, concrete list. Encrypt data at rest and in transit, using current standards. Put every account behind multi-factor login. Give people the least access they need to do their job, and nothing more. Log every access to patient data in a way nobody can quietly edit. Sign a BAA with any service that stores or processes that data. Host on infrastructure that supports all of the above, which usually means a plan built for regulated workloads rather than the cheapest tier.

You do not need a 40-page security policy to launch an MVP. You do need these six things done properly, because they are exactly the ones that are painful and expensive to add once real patient data is already in the system.

Deciding what to cut is the hardest, most valuable skill

An MVP is defined by what you leave out, and cutting is harder than building because everything on the list feels important to the person who wrote it. Here is the method that works. Take your feature list and sort every single item into two piles: “the product does not work without this” and “everything else.” The first pile is your MVP. The second pile is your roadmap. There is no third pile.

For most healthtech MVPs the core is a single loop. A patient logs symptoms and a provider reviews them. A user scans a label and gets a result. A caregiver records a reading and the system flags it. Build that one loop end to end, properly and compliantly, and stop. Cut the dashboard with twelve chart types. Cut the social feed, the gamification, the second user role, the third language, the admin panel you will not need until you have a hundred users. None of those are wrong. They are just not first.

When we built JoinBeet, this was the whole discipline: get the core nutrition and tracking loop working with wearable sync before adding anything else. It is not glamorous, and founders often push back because the cut features are the ones they pitched to investors. But scope discipline is the single habit that saves the most money and time in healthtech MVP development, and it is the one most first-time founders skip.

Validate before you build, not after

You can test a healthcare idea without writing the app, and you should. Show ten target clinicians or patients the prototype and ask one blunt question: what would stop you using this? In healthcare the blocker is rarely the feature you are worried about. It is trust, workflow fit, liability, or the simple fact that a busy clinician will not add a step to their day for a maybe. You want to hear that before you spend the money, not after the launch party.

This is also the part non-technical founders can own completely, and it is where they add the most value. You do not need to code to validate an idea, recruit clinicians, run interviews, and lead the product. You need to ask sharp questions and sit with the awkward answers instead of arguing with them. The founders who do this well walk into the build already knowing what the first version has to do, which is why their MVPs cost less and land better.

Build vs buy, and who should build it

Two decisions hide inside “how do I get this built.” The first is build versus buy. Build the part that is your actual product, the thing that makes you different and that you would be embarrassed to outsource. Rent everything else. Authentication, hosting, payments, even large parts of the compliance tooling are solved problems with mature vendors behind them. Writing your own version of any of them is a way to spend your runway on work no user will ever thank you for.

The second decision is who builds it: in-house, an agency, or freelancers. An in-house team is the right answer when you have the funding and a technical co-founder who can lead it, because you are hiring for the long haul.

Freelancers can be fine for a narrow piece of work, but stitching a compliant health product together from several independent contractors, none of whom owns the whole picture, is how compliance gaps appear. For most early healthtech startups, a senior team that has shipped compliant health software before will get you to a safe launch faster, because they have already made the expensive mistakes on someone else’s project. Whichever route you take, insist on senior people with real healthcare experience, and make ownership non-negotiable: the source code, the IP, and the documentation are yours.

How to choose an MVP development company (and the red flags)

If you go the agency route, the choice matters more in healthcare than anywhere else, because the cost of picking wrong is not just a bad app, it is a compliance liability with your name on it. Ask the questions that actually separate teams.

• Have you built HIPAA-compliant software before, and can you talk me through how you handled encryption, access control, and BAAs?
• Who owns the code and IP when we are done? (The only acceptable answer is “you do.”)
• Who will actually be on my project, and how senior are they?
• How do you decide what goes in the MVP versus the roadmap?
• What happens after launch, and what does support cost?

The red flags are just as telling. A team that treats compliance as your problem to sort out separately. A quote that is dramatically cheaper than everyone else, which usually means the compliance work is missing from the scope. Vague answers about who owns the code. No named senior engineer, just a promise of “our team.” And anyone who agrees to your full feature list on the first call without pushing back on scope has told you they will build whatever you say, right up until the money runs out.

Protecting your idea and your IP

Founders worry about someone stealing the idea, and while the idea is rarely the valuable part, the concern points at something real: ownership. Use a straightforward NDA with any team you talk to in depth. More importantly, make sure your contract states plainly that you own the source code, the intellectual property, and the documentation, with no lingering license back to the agency and no dependency that traps you. The nightmare is not a competitor copying your concept. It is discovering, a year in, that you cannot move your own product to another team because the code was never really yours. Own it from day one, in writing.

Web or mobile first?

Follow the user, not the trend. If your users are clinicians working at a desk, build web first. If they are patients logging something on the move, or you need the phone camera or sensors, build mobile first. Most healthtech MVPs do not need both on day one, and building both doubles the cost and the compliance surface for no extra learning. Pick the one your core loop lives on and ship it. When you genuinely need the other platform, that is a custom software decision for phase two, funded by what you learned in phase one.

After launch: measuring success and scaling up

Launching the MVP is the start of the real work, not the end. Decide before launch what success looks like, and keep it to two or three numbers you actually care about. For most healthtech MVPs that is activation (did people complete the core loop even once), retention (did they come back), and one outcome signal tied to your promise, whether that is readings logged, reviews completed, or time saved. Vanity metrics like downloads tell you nothing about whether the product works.

Then iterate from evidence, not opinion. The features you cut are not gone, they are waiting, and the MVP’s job is to tell you which of them earn their place. Scaling from an MVP to a full platform is mostly a sequence of these decisions: watch what real users do, add the next most valuable thing, keep the compliance foundations solid as you grow. The startups that scale well are the ones that treated the MVP as a question, not a smaller version of the answer.

The mistakes we see most often

• Building the full product and calling it an MVP.
• Leaving compliance and security for “after launch,” then paying three to five times more to retrofit it.
• Wiring up a third-party service without a BAA, the most common compliance failure there is.
• No clinician in the room until the app is already built.
• Two or three user types at launch when one would have proven the idea.
• Hiring the cheapest team, discovering they do not know healthcare, and paying twice to fix it.
• Custom-building auth, hosting, and infrastructure instead of using proven, BAA-eligible services.
• Measuring downloads instead of whether anyone completes the core loop.

Where to start with healthtech MVP development

If you take one thing from all of this, make it this: write down your core loop in a single sentence with no “ands,” confirm which rules apply to it before you design anything, and build that loop properly. Everything else is roadmap. That one habit is the difference between a healthtech startup that learns fast and cheap and one that spends its whole seed round finding out it built the wrong thing.

If you want a straight read on your specific product, scope, timeline, and what compliance will really take, a senior engineer who has shipped medical software will walk through it with you, no obligation. Book a discovery call.

Frequently asked questions

Ankit dhimmar

Ankit Dhimmar is the CTO of Mobilions, leading engineering across custom software, SaaS platforms, and cloud architecture. With over a decade building and scaling production systems, he focuses on the decisions that keep software reliable as it grows. He writes about software architecture, SaaS product engineering, and building systems that last.